SHREE GANESH REMEDIES LTD Share Price

SHREE GANESH REMEDIES LTD Share Price

NSE: SGRL
|
Pharmaceuticals
|
S Cap
₹ 740.00
+₹35.20 (4.99%)
1D
Last updated 23 Sep, 2026, 15:29 IST

SHREE GANESH REMEDIES LTD Share Price Today

As of 23 Sep 2026, SHREE GANESH REMEDIES LTD share price is ₹740.00. The stock opened at ₹705.10, compared to its previous close of ₹704.80. During today's trading session, SHREE GANESH REMEDIES LTD share price moved in the range of ₹705.10 to ₹749.85, with an average price of ₹727.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹477.05 and a high of ₹749.85. On the performance front, SHREE GANESH REMEDIES LTD share price has increased by 2.99% over the last six months and is up 2.99% on a year-on-year basis.

₹705.10
4.99% up today
₹749.85
1D LOW
1D HIGH

SHREE GANESH REMEDIES LTD Returns Calculator

Circuit
L
H
₹563.85
₹845.75
52-week
L
H
₹477.05
₹749.85

About SHREE GANESH REMEDIES LTD

SHREE GANESH REMEDIES LTD Share Price
ISIN
INE414Y01015
Sector Market Cap
₹ 923.54 Cr

Shree Ganesh Remedies Limited is an India-based company, which is engaged in the business of bulk drug intermediates. The Company's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. Its human health API intermediates include antipsychotic, antidepression, oncology, diabetic, and diuretic. Its specialty & fine chemicals include aroma & health industry, agro-industry, polymer industry, and electronics industry. Its veterinary API intermediates include feed additives, antiparasitic, and anti-inflammatory. Its anti-arrhythmic API intermediates include amiodarone intermediates, dronedarone intermediates, and mesalazine intermediates. Its anti-cancer API intermediates include cabozantinib intermediates, gefitinib intermediates, olaparib intermediates, and raloxifene intermediates. Its anti-parasitic API intermediates include flubendazole intermediates, nitazoxanide intermediates, and praziquantel intermediates.

SHREE GANESH REMEDIES LTD Financial Highlights

  • Revenue: SHREE GANESH REMEDIES LTD reported revenue of ₹112.32 crore in FY26 vs ₹112.33 crore in FY25. It showed a decrease of 0.01% on a yearly basis.
  • Operating Profit: SHREE GANESH REMEDIES LTD reported an operating profit of ₹24.01 crore in FY26 vs ₹31.27 crore in FY25. It showed a decrease of 23.22% on a year-on-year basis.
  • Net Profit: SHREE GANESH REMEDIES LTD reported a net profit of ₹17.76 crore in FY26 vs ₹23.07 crore in FY25. It showed a decrease of 23.02% on a yearly basis.

SHREE GANESH REMEDIES LTD Quarterly Result Highlights

  • SHREE GANESH REMEDIES LTD reported revenue of ₹15.30 crore in Jun 2026, compared with ₹34.22 crore in Mar 2026, representing a decrease of 55.29% on a quarter-on-quarter (QoQ) basis.
  • SHREE GANESH REMEDIES LTD reported an operating profit of ₹1.53 crore in Jun 2026, compared with ₹8.72 crore in Mar 2026, representing a decrease of 82.45% on a quarter-on-quarter (QoQ) basis.
  • SHREE GANESH REMEDIES LTD reported a profit of ₹1.12 crore in Jun 2026, compared with ₹6.27 crore in Mar 2026, reflecting a decrease of 82.14% on a QoQ basis.
  • The earnings per share (EPS) of SHREE GANESH REMEDIES LTD stood at ₹13.83 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.84%
FII
0.00%
Other DII
0.52%
Retail and other
26.64%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.01%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
903.51
P/E
58.55
P/B
5.54
ROE
10.90%
D/E
0.19
ROCE
14.23%
Div. Yield
0.00%
EPS(TTM)
13.84
Turnover
0.48
EV/EBITDA
27.41
Net Margin
16.26%
Op. Margin
34.82%
ROA
7.43%
Quick Ratio
2.85
Curr. Ratio
7.00
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Shree Ganesh Rem outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Shree Ganesh Rem appears overvalued compared to its peers
Step 1 of 5
Earnings
Very Poor
Shree Ganesh Rem revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,02,410.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SHREE GANESH REMEDIES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2020
Revenue₹109.29₹108.60₹125.90₹64.02
Other Income₹3.03₹3.73₹3.07₹3.91
Total Revenue₹112.32₹112.33₹128.97₹67.93
Total Expenses₹88.30₹81.06₹90.81₹54.34
Profit Before Tax₹24.01₹31.27₹38.16₹13.59
Tax₹6.26₹8.20₹10.05₹3.12
Profit After Tax₹17.76₹23.07₹28.11₹10.47
EPS - Basic₹13.83₹17.96₹22.34₹11.67
EPS - Diluted₹13.83₹17.96₹22.34₹11.67

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2020
Profit before tax₹24.01₹31.27₹38.16₹10.47
Income before WC changes₹35.64₹42.45₹44.05₹9.93
Change in Assets-₹11.03₹0.46₹1.41-₹9.82
Change in Liabilities₹3.96-₹2.19-₹6.88₹4.48
Change in WC-₹7.07-₹1.73-₹5.47-₹5.34
Cash flow from Operations₹23.74₹30.66₹30.45₹4.59
Cash flow from Investing-₹9.89-₹35.66-₹33.01-₹2.91
Cash flow from Financing-₹11.70-₹1.09₹9.84-₹0.48
Total Cash Flow₹2.16-₹6.08₹7.28₹1.20
Cash (Start of the year)₹9.95₹15.85₹8.66₹1.13
Cash (End of the year)₹13.40₹9.95₹15.85₹2.33

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2020
Non-Current Assets₹121.82₹114.37₹100.73₹21.46
Current Assets₹85.86₹77.58₹70.20₹33.82
Total Assets₹207.69₹191.94₹170.94₹55.28
Current Liabilities₹21.69₹16.18₹18.68₹10.38
Net Current Asset₹64.17₹61.39₹51.52₹23.44
Non-Current Liabilities₹23.03₹30.60₹30.16₹2.65
Equity Capital₹162.97₹145.16₹122.10₹42.25
Total Equity & Liabilities₹207.69₹191.94₹170.94₹55.28

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹109.29₹108.60₹125.90₹91.36
Other Income₹3.03₹3.73₹3.07₹0.72
Total Revenue₹112.32₹112.33₹128.97₹92.07
Total Expenses₹88.30₹81.03₹90.80₹71.84
Profit Before Tax₹24.01₹31.30₹38.17₹20.24
Tax₹6.24₹8.20₹10.05₹5.05
Profit After Tax₹17.77₹23.10₹28.12₹15.18
EPS - Basic₹13.84₹17.98₹22.35₹12.54
EPS - Diluted₹13.84₹17.98₹22.35₹12.54

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹24.01₹31.30₹38.17₹20.24
Income before WC changes₹35.63₹42.45₹44.05₹26.72
Change in Assets-₹11.03₹0.46₹1.41-₹11.23
Change in Liabilities₹3.96-₹2.19-₹6.88₹1.61
Change in WC-₹7.07-₹1.73-₹5.47-₹9.62
Cash flow from Operations₹23.75₹30.66₹30.45₹17.10
Cash flow from Investing-₹9.89-₹35.66-₹33.09-₹51.09
Cash flow from Financing-₹11.70-₹1.06₹9.85₹38.66
Total Cash Flow₹2.17-₹6.05₹7.21₹4.67
Cash (Start of the year)₹9.90₹15.78₹8.66₹3.88
Cash (End of the year)₹13.36₹9.90₹15.78₹8.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹121.91₹114.45₹100.82₹75.75
Current Assets₹85.83₹77.53₹70.13₹62.22
Total Assets₹207.74₹191.98₹170.94₹137.97
Current Liabilities₹21.69₹16.18₹18.68₹20.11
Net Current Asset₹64.14₹61.35₹51.45₹42.11
Non-Current Liabilities₹23.03₹30.60₹30.16₹30.66
Equity Capital₹163.02₹145.19₹122.11₹87.20
Total Equity & Liabilities₹207.74₹191.98₹170.94₹137.97
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
76.93
Bullish
ATR (14)
40.94
Neutral
STOCH(9,6)
70.67
Neutral
ADX(9)
72.19
Bearish
ROC(12)
3.03
Bullish
WillR(14)
-29.33
Neutral
Period
Simple value
Exponential vaue
5D
690.03
695.17
10D
676.05
683.16
20D
646.18
671.55
50D
616.57
0
100D
616.57
0
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SHREE GANESH REMEDIES LTD Share Price
SHREE GANESH REMEDIES LTD
Pharmaceuticals
Add Stock
Add Another

SHREE GANESH REMEDIES LTD Share Price FAQs

SHREE GANESH REMEDIES LTD share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837